Iterum Therapeutics PLC (ITRM)
1.55
-0.03
(-1.90%)
USD |
NASDAQ |
May 03, 16:00
1.53
-0.02
(-1.29%)
After-Hours: 20:00
Iterum Therapeutics Enterprise Value: 20.69M for May 3, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 20.69M |
| May 02, 2024 | 21.18M |
| May 01, 2024 | 21.35M |
| April 30, 2024 | 20.36M |
| April 29, 2024 | 20.52M |
| April 26, 2024 | 22.67M |
| April 25, 2024 | 21.02M |
| April 24, 2024 | 20.69M |
| April 23, 2024 | 21.05M |
| April 22, 2024 | 21.05M |
| April 19, 2024 | 18.58M |
| April 18, 2024 | 18.58M |
| April 17, 2024 | 19.07M |
| April 16, 2024 | 18.91M |
| April 15, 2024 | 20.88M |
| April 12, 2024 | 21.05M |
| April 11, 2024 | 22.04M |
| April 10, 2024 | 22.04M |
| April 09, 2024 | 22.53M |
| April 08, 2024 | 23.03M |
| April 05, 2024 | 24.01M |
| April 04, 2024 | 25.83M |
| April 03, 2024 | 20.56M |
| April 02, 2024 | 21.38M |
| April 01, 2024 | 22.04M |
| Date | Value |
|---|---|
| March 28, 2024 | 20.32M |
| March 27, 2024 | 21.14M |
| March 26, 2024 | 20.65M |
| March 25, 2024 | 20.49M |
| March 22, 2024 | 21.31M |
| March 21, 2024 | 20.98M |
| March 20, 2024 | 20.98M |
| March 19, 2024 | 22.13M |
| March 18, 2024 | 21.80M |
| March 15, 2024 | 19.01M |
| March 14, 2024 | 18.84M |
| March 13, 2024 | 19.99M |
| March 12, 2024 | 22.46M |
| March 11, 2024 | 21.64M |
| March 08, 2024 | 20.49M |
| March 07, 2024 | 19.83M |
| March 06, 2024 | 19.50M |
| March 05, 2024 | 15.81M |
| March 04, 2024 | 15.40M |
| March 01, 2024 | 16.38M |
| February 29, 2024 | 15.40M |
| February 28, 2024 | 12.30M |
| February 27, 2024 | 12.84M |
| February 26, 2024 | 12.30M |
| February 23, 2024 | 12.17M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-25.88M
Minimum
Sep 23 2022
394.05M
Maximum
Feb 10 2021
42.54M
Average
26.35M
Median
Nov 01 2019
Enterprise Value Benchmarks
| Alkermes PLC | 3.615B |
| Endo International PLC | -777.78M |
| Jazz Pharmaceuticals PLC | 10.83B |
| Medtronic PLC | 125.48B |
| Perrigo Co PLC | 7.766B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -12.36M |
| Total Expenses (Quarterly) | 11.43M |
| EPS Diluted (Quarterly) | -0.94 |
| Earnings Yield | -191.6% |
| Normalized Earnings Yield | -6406.45 |